FNIAX
Price
$47.59
Change
+$0.48 (+1.02%)
Updated
Sep 4 closing price
Net Assets
23.84B
RGEBX
Price
$82.44
Change
+$0.19 (+0.23%)
Updated
Sep 5 closing price
Net Assets
332.38B
Interact to see
Advertisement

FNIAX vs RGEBX

Header iconFNIAX vs RGEBX Comparison
Open Charts FNIAX vs RGEBXBanner chart's image
Fidelity Advisor New Insights A
Price$47.59
Change+$0.48 (+1.02%)
VolumeN/A
Net Assets23.84B
American Funds Growth Fund of Amer R2E
Price$82.44
Change+$0.19 (+0.23%)
VolumeN/A
Net Assets332.38B
FNIAX vs RGEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FNIAX vs. RGEBX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FNIAX is a Buy and RGEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 332B vs. FNIAX (23.8B). FNIAX pays higher dividends than RGEBX: FNIAX (0.02) vs RGEBX (0.00). FNIAX was incepted earlier than RGEBX: FNIAX (22 years) vs RGEBX (11 years). RGEBX (1.09) is less costly to investors than FNIAX (0.90). RGEBX is a more actively managed with annual turnover of: 25.00 vs. FNIAX (18.00). FNIAX has a lower initial minimum investment than RGEBX: FNIAX (0) vs RGEBX (250). FNIAX annual gain was more profitable for investors over the last year : 19.62 vs. RGEBX (17.59). RGEBX return over 5 years is better than : 38.71 vs. FNIAX (30.38).
FNIAXRGEBXFNIAX / RGEBX
Total Expense Ratio0.901.0983%
Annual Report Gross Expense Ratio0.901.0983%
Fund Existence22 years11 years-
Gain YTD14.22715.39892%
Front Load6%N/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets23.8B332B7%
Annual Yield % from dividends0.020.00-
Returns for 1 year19.6217.59112%
Returns for 3 years62.1857.61108%
Returns for 5 years30.3838.7178%
Returns for 10 years79.9491.4487%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARTV3.610.50
+16.08%
Artiva Biotherapeutics Inc
DNLI15.430.64
+4.33%
Denali Therapeutics
FRPH25.47-0.03
-0.12%
FRP Holdings
CNA48.01-0.94
-1.92%
CNA Financial Corp
PMAX0.26-0.03
-9.59%
Powell Max Ltd